Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
复制标题
DOI:
10.1172/jci10498
复制
发表时间:
2000-12-01
影响因子:
15.9
通讯作者:
Zlokovic, BV
中科院分区:
文献类型:
--
作者:
Shibata, M;Yamada, S;Zlokovic, BV
Elimination of amyloid-beta peptide (A beta) from the brain is poorly understood. After intracerebral microinjections in young mice,I-125-A beta (1.40) was rapidly removed from the brain (t(1/2) less than or equal to 25 minutes), mainly by vascular transport across the blood-brain barrier (BBB). The efflux transport system for A beta (1.40) at the BBB was half saturated at 15.3 nM, and the maximal transport capacity was reached between 70 nM and 100 nM. A beta (1.40) clearance was substantially inhibited by the receptor-associated protein, and by antibodies against LDL receptor-related protein-1 (LRP-1) and alpha (2)-macroglobulin (alpha M-2), As compared to adult wild-type mice, clearance was significantly reduced in young and old apolipoprotein E (apoE) knockout mice, and in old wild-type mice. There was no evidence that A beta was metabolized in brain interstitial fluid and degraded to smaller peptide fragments and amino acids before its transport across the BBB into the circulation. LRP-1, although abundant in brain microvessels in young mice, was downregulated in older animals, and this downregulation correlated with regional A beta accumulation in brains of Alzheimer's disease (AD) patients. We conclude that the BBB removes A beta from the brain largely via age-dependent, LRP-1-mediated transport that is influenced by alpha M-2 and/or apoE, and may be impaired in AD.